Lifecore Biomedical Inc (LFCR) Continues Winning Contracts, Ignored by the Market
Laughing Water Capital, an investment management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here.
Lifecore Biomedical Inc. (LFCR)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Wynnefield Capital Nelson Obus | 4,703,216 | $24,691,884 | 16.98% | |
| 2. | Legion Partners Asset Management Ted White And Christopher Kiper | 4,461,823 | $23,424,571 | 57.75% | |
| 3. | Greenhaven Road Investment Management Scott Stewart Miller | 3,190,769 | $16,751,537 | -10% | 10.88% |
| 4. | 325 Capital Michael Braner, Daniel Friedberg And Anil Shrivastava | 2,895,881 | $15,203,375 | +34% | 3.62% |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 177,471 | $931,724 | +205% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.74 | 17,000 | $97,580.00 | 559,717 | 2025-01-08 | Filing | |
| $4.10 | 169,753 | $695,987.30 | 2,607,433 | 2024-10-03 | Filing | |
| $4.10 | 122,930 | $504,013.00 | 2,095,783 | 2024-10-03 | Filing | |
| $4.10 | 152,102 | $623,618.20 | 319,286 | 2024-10-03 | Filing | |
| $4.10 | 1,311,312 | $5,376,379.20 | 4,084,268 | 2024-10-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.12 | 150,419 | $1,071,554.87 | 264,180 | 2025-05-28 | Filing | |
| $6.50 | 1,139,504 | $7,411,561.92 | 414,599 | 2025-05-27 | Filing | |
| $6.75 | 96,137 | $649,386.21 | 1,554,103 | 2025-05-23 | Filing | |
| $7.00 | 12,334 | $86,352.80 | 1,650,240 | 2025-05-13 | Filing | |
| $7.03 | 45,698 | $321,426.02 | 1,662,574 | 2025-05-12 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,013,093 | $10,568,739 | 0% | |
| 2. | 1,288,621 | $6,765,260 | 0% | |
| 3. | 855,500 | $4,492,587 | 0% | |
| 4. | 769,360 | $4,039,141 | 0% | |
| 5. | 668,031 | $3,507,163 | 0% |
News See All
Can Lifecore Biomedical, Inc. (LFCR) Unlock Long-Term Value Through Expanding Biopharma Collaborations?
TheFly reported on June 16 that Barrington increased its price target on LFCR to $6.50 from $6.00 while reaffirming an Outperform rating on the shares.
12 Best Low-Priced Pharma Stocks to Buy Right Now
Investors looking for large returns without making a sizable initial commitment are still drawn to low-priced companies.
Laughing Water Capital’s Insights on Lifecore Biomedical (LFCR)
Laughing Water Capital, an investment management company, released its first-quarter 2026 investor letter. A copy of the letter can be downloaded here.
What Contributes to Lifecore Biomedical's (LFCR) Distinct Competitive Advantage?
Laughing Water Capital, an investment management company, released its fourth-quarter 2025 investor letter.
Here’s the Analysis of LifeCore’s (LFCR) Growth Potential
Greenhaven Road Capital, an investment management company, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Here’s Why Lifecore Biomedical Inc (LFCR) Declined 22% at the End of Q3
Laughing Water Capital, an investment management company, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Does LifeCore (LFCR) Have a High Expected Value?
Greenhaven Road Capital, an investment management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here. A copy of the letter can be downloaded here.
Laughing Water Capital’s View on Lifecore Biomedical (LFCR)
Laughing Water Capital, an investment management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here.
What Makes Lifecore Biomedical (LFCR) a Beneficiary of the Trade Policies?
Greenhaven Road Capital, an investment management company, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Hedge Fund Resource Center